Review Article|Articles in Press

Advances in Diagnostics of Sexually Transmitted Infections

Published:March 15, 2023DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance.
        (Available at:) (Accessed October 26, 2022)
        • Kreisel K.M.
        • Weston E.J.
        • St. Cyr S.B.
        • et al.
        Estimates of the prevalence and incidence of chlamydia and gonorrhea among US men and women, 2018.
        Sexual Trans Dis. 2021; 48: 222-231
        • Kumar S.
        • Chesson H.W.
        • Spicknall I.H.
        • et al.
        The estimated lifetime medical cost of chlamydia, gonorrhea, and trichomoniasis in the United States, 2018.
        Sex Transm Dis. 2021; 48: 238-246
        • Workowski K.A.
        • Bachmann L.H.
        • Chan P.A.
        • et al.
        Sexually transmitted infections treatment guidelines, 2021.
        MMWR Recomm Rep (Morb Mortal Wkly Rep). 2021; 70: 1-187
        • Van Der Pol B.
        Editorial Commentary: Trichomonas vaginalis Infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
        Clin Infect Dis. 2007; 44: 23-25
        • Stemmer S.M.
        • Mordechai E.
        • Adelson M.E.
        • et al.
        Trichomonas vaginalis is most frequently detected in women at the age of peri-/premenopause: an unusual pattern for a sexually transmitted pathogen.
        Am J Obstet Gynecol. 2018; 218: 328.e1-328.e13
        • Van Gerwen O.T.
        • Craig-Kuhn M.C.
        • Jones A.T.
        • et al.
        Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis.
        BJOG. 2021; 128: 1907-1915
        • Masha S.C.
        • Cools P.
        • Sanders E.J.
        • et al.
        Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis.
        Sex Transm Infect. 2019; 95: 36-42
        • Manhart L.E.
        • Holmes K.K.
        • Hughes J.P.
        • et al.
        Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection.
        Am J Public Health. 2007; 97: 1118-1125
        • Lis R.
        • Rowhani-Rahbar A.
        • Manhart L.E.
        Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis.
        Clin Infect Dis. 2015; 61: 418-426
        • Peebles K.
        • Velloza J.
        • Balkus J.E.
        • et al.
        High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis.
        Sex Transm Dis. 2019; 46: 304-311
        • Allsworth J.E.
        • Peipert J.F.
        Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data.
        Obstet Gynecol. 2007; 109: 114-120
        • Rowley J.
        • Vander Hoorn S.
        • Korenromp E.
        • et al.
        Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.
        Bull World Health Organ. 2019; 97: 548-562P
        • Johnston C.
        • Magaret A.
        • Son H.
        • et al.
        Viral shedding 1 year following first-episode genital HSV-1 infection.
        JAMA. 2022; 328: 1730
        • McQuillan G.
        • Kruszon-Moran D.
        • Flagg E.W.
        • et al.
        Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14-49: United States, 2015-2016.
        NCHS Data Brief. 2018; : 1-8
        • Solomon M.M.
        • Mayer K.H.
        • Glidden D.V.
        • et al.
        Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.
        Clin Infect Dis. 2014; 59: 1020-1026
        • Freeman E.E.
        • Weiss H.A.
        • Glynn J.R.
        • et al.
        Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.
        AIDS. 2006; 20: 73-83
        • Babu T.M.
        • Urban M.A.
        • Augenbraun M.H.
        in: Bennett J.E. Dolin R. Blaser M.J. Mandell Douglas Bennett’s Principles and Practice of Infectious Diseases. Ninth Edition. Elsevier, Philadelphia, PA2019: 1452-1461
        • Getman D.
        • Jiang A.
        • O’Donnell M.
        • et al.
        Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States.
        J Clin Microbiol. 2016; 54: 2278-2283
        • Broache M.
        • Cammarata C.L.
        • Stonebraker E.
        • et al.
        Performance of a vaginal panel assay compared with the clinical diagnosis of vaginitis.
        Obstet Gynecol. 2021; 138: 853-859
        • Van Der Pol B.
        • Daniel G.
        • Kodsi S.
        • et al.
        Molecular-based testing for sexually transmitted infections using samples previously collected for vaginitis diagnosis.
        Clin Infect Dis. 2019; 68: 375-381
        • Langenberg A.G.
        • Corey L.
        • Ashley R.L.
        • et al.
        A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
        N Engl J Med. 1999; 341: 1432-1438
        • Cheng Y.
        • Paintsil E.
        • Ghebremichael M.
        Syndromic versus laboratory diagnosis of sexually transmitted infections in men in Moshi district of Tanzania.
        AIDS Res Treat. 2020; 2020: 7607834
        • Maina A.N.
        • Mureithi M.W.
        • Ndemi J.K.
        • et al.
        Diagnostic accuracy of the syndromic management of four STIs among individuals seeking treatment at a health centre in Nairobi, Kenya: a cross-sectional study.
        Pan Afr Med J. 2021; 40: 138
        • Barry M.S.
        • Ba Diallo A.
        • Diadhiou M.
        • et al.
        Accuracy of syndromic management in targeting vaginal and cervical infections among symptomatic women of reproductive age attending primary care clinics in Dakar, Senegal.
        Trop Med Int Health. 2018; 23: 541-548
        • Loh A.J.W.
        • Ting E.L.
        • Wi T.E.
        • et al.
        The diagnostic accuracy of syndromic management for genital ulcer disease: a systematic review and meta-analysis.
        Front Med. 2021; 8: 806605
        • Gaydos C.A.
        • Van Der Pol B.
        • Jett-Goheen M.
        • et al.
        Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
        J Clin Microbiol. 2013; 51: 1666-1672
        • Van Der Pol B.
        • Taylor S.N.
        • Mena L.
        • et al.
        Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea.
        JAMA Netw Open. 2020; 3: e204819
        • Harding-Esch E.M.
        • Nori A.V.
        • Hegazi A.
        • et al.
        Impact of deploying multiple point-of-care tests with a “sample first” approach on a sexual health clinical care pathway. A service evaluation.
        Sex Transm Infect. 2017; 93: 424-429
        • Gettinger J.
        • Van Wagoner N.
        • Daniels B.
        • et al.
        Patients are willing to wait for rapid sexually transmitted infection results in a university student health clinic.
        Sex Transm Dis. 2020; 47: 67-69
        • Taylor S.N.
        • DiCarlo R.P.
        • Martin D.H.
        Comparison of methylene blue/gentian violet stain to gram’s stain for the rapid diagnosis of gonococcal urethritis in men.
        Sex Transm Dis. 2011; 38: 995-996
        • Rietmeijer C.A.
        • Mettenbrink C.J.
        Recalibrating the gram stain diagnosis of male urethritis in the era of nucleic acid amplification testing.
        Sex Transm Dis. 2012; 39: 18-20
        • Marrazzo J.M.
        • Handsfield H.H.
        • Whittington W.L.H.
        Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis.
        Obstet Gynecol. 2002; 100: 579-584
        • Marrazzo J.M.
        • Martin D.H.
        Management of women with cervicitis.
        Clin Infect Dis. 2007; 44: S102-S110
        • Hobbs M.M.
        • Seña A.C.
        Modern diagnosis of Trichomonas vaginalis infection: Table 1.
        Sex Transm Infect. 2013; 89: 434-438
        • Kingston M.A.
        • Bansal D.
        • Carlin E.M.
        “Shelf life” of Trichomonas vaginalis.
        Int J STD AIDS. 2003; 14: 28-29
        • Trubiano J.A.
        • Thursky K.A.
        • Stewardson A.J.
        • et al.
        Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation.
        Clin Infect Dis. 2017; 65: 166-174
        • Amsel R.
        • Totten P.A.
        • Spiegel C.A.
        • et al.
        Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.
        Am J Med. 1983; 74: 14-22
        • Coleman J.S.
        • Gaydos C.A.
        Molecular diagnosis of bacterial vaginosis: an update.
        J Clin Microbiol. 2018; 56 (003422-e418)
        • Belley-Montfort L.
        • Lebed J.
        • Smith B.
        • et al.
        P248 Sensitivity of the Amsel’s criteria compared to the Nugent score in absence and in presence of <em>trichomonas vaginalis</em> (TV) and/or <em>candida</em> SPP among women with symptomatic vaginitis/vaginosis.
        Sex Transm Infect. 2015; 91: A97
        • Theel E.S.
        • Katz S.S.
        • Pillay A.
        Molecular and direct detection tests for treponema pallidum subspecies pallidum: a review of the literature, 1964-2017.
        Clin Infect Dis. 2020; 71: S4-S12
        • Watchirs Smith L.A.
        • Hillman R.
        • Ward J.
        • et al.
        Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics.
        Sex Transm Infect. 2013; 89: 320-326
        • Wisniewski C.A.
        • White J.A.
        • Michel C.E.C.
        • et al.
        Optimal method of collection of first-void urine for diagnosis of Chlamydia trachomatis infection in men.
        J Clin Microbiol. 2008; 46: 1466-1469
        • Koczula K.M.
        • Gallotta A.
        Lateral flow assays.
        Essays Biochem. 2016; 60: 111-120
        • Bradshaw C.S.
        • Morton A.N.
        • Garland S.M.
        • et al.
        Evaluation of a Point-of-Care Test, BVBlue, and Clinical and Laboratory Criteria for Diagnosis of Bacterial Vaginosis.
        J Clin Microbiol. 2005; 43: 1304-1308
        • Myziuk L.
        • Romanowski B.
        • Johnson S.C.
        BVBlue test for diagnosis of bacterial vaginosis.
        J Clin Microbiol. 2003; 41: 1925-1928
        • Sumeksri P.
        • Koprasert C.
        • Panichkul S.
        BVBLUE test for diagnosis of bacterial vaginosis in pregnant women attending antenatal care at Phramongkutklao Hospital.
        J Med Assoc Thai. 2005; 88: S7-S13
        • West B.
        • Morison L.
        • Van Der Loeff M.S.
        • et al.
        Evaluation of a New Rapid Diagnostic Kit (FemExam) for Bacterial Vaginosis in Patients With Vaginal Discharge Syndrome in The Gambia.
        Sex Transm Dis. 2003; 30: 483-489
        • Seña A.C.
        • White B.L.
        • Sparling P.F.
        Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century.
        Clin Infect Dis. 2010; 51: 700-708
        • Jafari Y.
        • Peeling R.W.
        • Shivkumar S.
        • et al.
        Are Treponema pallidum specific rapid and point-of-care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta-analysis.
        PLoS One. 2013; 8: e54695
        • Causer L.M.
        • Kaldor J.M.
        • Conway D.P.
        • et al.
        An evaluation of a novel dual treponemal/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infection.
        Clin Infect Dis. 2015; 61: 184-191
        • Herbst de Cortina S.
        • Bristow C.C.
        • Joseph Davey D.
        • et al.
        A systematic review of point of care testing for chlamydia trachomatis, neisseria gonorrhoeae, and trichomonas vaginalis.
        Infect Dis Obstet Gynecol. 2016; 2016: 4386127
        • Rönn M.M.
        • Menzies N.A.
        • Gift T.L.
        • et al.
        Potential for point-of-care tests to reduce chlamydia-associated burden in the United States: a mathematical modeling analysis.
        Clin Infect Dis. 2020; 70: 1816-1823
        • Goldenberg S.D.
        • Finn J.
        • Sedudzi E.
        • et al.
        Performance of the GeneXpert CT/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima Samples.
        J Clin Microbiol. 2012; 50: 3867-3869
        • Gaydos C.A.
        • Beqaj S.
        • Schwebke J.R.
        • et al.
        Clinical validation of a test for the diagnosis of vaginitis.
        Obstet Gynecol. 2017; 130: 181-189
        • Morris S.R.
        • Bristow C.C.
        • Wierzbicki M.R.
        • et al.
        Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.
        Lancet Infect Dis. 2021; 21: 668-676
        • Gaydos C.
        • Schwebke J.
        • Dombrowski J.
        • et al.
        Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.
        Expert Rev Mol Diagn. 2017; 17: 303-306
        • Gaydos C.A.
        • Hobbs M.
        • Marrazzo J.
        • et al.
        Rapid diagnosis of trichomonas vaginalis by testing vaginal swabs in an isothermal helicase-dependent AmpliVue assay.
        Sex Transm Dis. 2016; 43: 369-373
        • Song B.
        HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.
        Sex Transm Infect. 2004; 80: 113-117
        • Whittington W.L.H.
        • Celum C.L.
        • Cent A.
        • et al.
        Use of a glycoprotein g-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.
        Sex Transm Dis. 2001; 28: 99-104
        • Turner K.R.
        • Wong E.H.
        • Kent C.K.
        • et al.
        Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
        Sex Transm Dis. 2002; 29: 422-425
        • Eing B.R.
        • Lippelt L.
        • Lorentzen E.U.
        • et al.
        Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
        J Clin Microbiol. 2002; 40: 407-413
        • Agyemang E.
        • Le Q.A.
        • Warren T.
        • et al.
        Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting.
        Sex Transm Dis. 2017; 44: 763-767
        • Morrow R.
        • Friedrich D.
        Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
        Clin Microbiol Infect. 2006; 12: 463-469
        • Tuddenham S.
        • Katz S.S.
        • Ghanem K.G.
        Syphilis laboratory guidelines: performance characteristics of nontreponemal antibody tests.
        Clin Infect Dis. 2020; 71: S21-S42
        • Centers for Disease Control and Prevention (CDC)
        Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006.
        MMWR Morb Mortal Wkly Rep. 2008; 57: 872-875
        • Centers for Disease Control and Prevention (CDC)
        Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 133-137
        • Centers for Disease Control and Prevention
        Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.
        MMWR Recomm Rep (Morb Mortal Wkly Rep). 2014; 63: 1-19
        • Bignell C.
        • Ison C.A.
        • Jungmann E.
        Sex Transm Infect. 2006; 82: iv6-iv9
        • Schink J.C.
        • Keith L.G.
        Problems in the culture diagnosis of gonorrhea.
        J Reprod Med. 1985; 30: 244-249
        • Sobel J.D.
        Vulvovaginal candidosis.
        Lancet. 2007; 369: 1961-1971
        • Wald A.
        • Huang M.L.
        • Carrell D.
        • et al.
        Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.
        J Infect Dis. 2003; 188: 1345-1351
        • Lunny C.
        • Taylor D.
        • Hoang L.
        • et al.
        Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis.
        PLoS One. 2015; 10: e0132776
        • Hobbs M.M.
        • van der Pol B.
        • Totten P.
        • et al.
        From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.
        Sex Transm Dis. 2008; 35: 8-13
        • Chernesky M.
        • Freund G.G.
        • Hook E.
        • et al.
        Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
        J Clin Microbiol. 2007; 45: 2434-2438
        • Cosentino L.A.
        • Danby C.S.
        • Rabe L.K.
        • et al.
        Use of nucleic acid amplification testing for diagnosis of extragenital sexually transmitted infections.
        J Clin Microbiol. 2017; 55: 2801-2807
        • van der Helm J.J.
        • Hoebe C.J.P.A.
        • van Rooijen M.S.
        • et al.
        High performance and acceptability of self-collected rectal swabs for diagnosis of chlamydia trachomatis and neisseria gonorrhoeae in men who have sex with men and women.
        Sex Transm Dis. 2009; 36: 493-497
        • Ward H.
        • Alexander S.
        • Carder C.
        • et al.
        The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study.
        Sex Transm Infect. 2009; 85: 173-175
        • Leslie D.E.
        • Azzato F.
        • Karapanagiotidis T.
        • et al.
        Development of a real-time PCR assay to detect Treponema pallidum in clinical specimens and assessment of the assay’s performance by comparison with serological testing.
        J Clin Microbiol. 2007; 45: 93-96
        • Heymans R.
        • van der Helm J.J.
        • de Vries H.J.C.
        • et al.
        Clinical value of Treponema pallidum real-time PCR for diagnosis of syphilis.
        J Clin Microbiol. 2010; 48: 497-502
        • Gayet-Ageron A.
        • Sednaoui P.
        • Lautenschlager S.
        • et al.
        Use of Treponema pallidum PCR in testing of ulcers for diagnosis of primary syphilis.
        Emerg Infect Dis. 2015; 21: 127-129
        • Grange P.A.
        • Gressier L.
        • Dion P.L.
        • et al.
        Evaluation of a PCR test for detection of treponema pallidum in swabs and blood.
        J Clin Microbiol. 2012; 50: 546-552
        • Klausner J.D.
        • Bristow C.C.
        • Soge O.O.
        • et al.
        Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
        Clin Infect Dis. 2021; 73: 298-303
        • Read T.R.H.
        • Fairley C.K.
        • Murray G.L.
        • et al.
        Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation.
        Clin Infect Dis. 2019; 68: 554-560
        • Durukan D.
        • Read T.R.H.
        • Murray G.
        • et al.
        Resistance-guided antimicrobial therapy using doxycycline–moxifloxacin and doxycycline–2.5 g azithromycin for the treatment of mycoplasma genitalium infection: efficacy and tolerability.
        Clin Infect Dis. 2020; 71: 1461-1468
        • LeFevre M.L.
        U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2014; 161: 902-910
        • US Preventive Services Task Force
        • Curry S.J.
        • Krist A.H.
        • et al.
        Screening for cervical cancer: US preventive services task force recommendation statement.
        JAMA. 2018; 320: 674
        • US Preventive Services Task Force
        • Bibbins-Domingo K.
        • Grossman D.C.
        • et al.
        Serologic screening for genital herpes infection: US preventive services task force recommendation statement.
        JAMA. 2016; 316: 2525-2530
        • Golden M.R.
        • Workowski K.A.
        • Bolan G.
        Developing a public health response to mycoplasma genitalium.
        J Infect Dis. 2017; 216: S420-S426
        • Lin J.S.
        • Eder M.
        • Bean S.
        Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive services task force.
        Agency for Healthcare Research and Quality (US), 2018 (Available at:) (Accessed August 23, 2022)
        • Matthias J.M.
        • Rahman M.M.
        • Newman D.R.
        • et al.
        Effectiveness of prenatal screening and treatment to prevent congenital syphilis, Louisiana and Florida, 2013-2014.
        Sex Transm Dis. 2017; 44: 498-502
        • Exten C.
        • Pinto C.N.
        • Gaynor A.M.
        • et al.
        Direct-to-consumer sexually transmitted infection testing services: a position statement from the American Sexually Transmitted Diseases Association.
        Sex Transm Dis. 2021; 48: e155-e159
        • Farley T.A.
        • Cohen D.A.
        • Elkins W.
        Asymptomatic sexually transmitted diseases: the case for screening.
        Prev Med. 2003; 36: 502-509
        • Handsfield H.H.
        • Lipman T.O.
        • Harnisch J.P.
        • et al.
        Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance.
        N Engl J Med. 1974; 290: 117-123
        • Klouman E.
        • Masenga E.J.
        • Sam N.E.
        • et al.
        Asymptomatic gonorrhoea and chlamydial infection in a population-based and work-site based sample of men in Kilimanjaro, Tanzania.
        Int J STD AIDS. 2000; 11: 666-674
        • Falk L.
        • Fredlund H.
        • Jensen J.S.
        Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis.
        Sex Transm Infect. 2004; 80: 289-293
        • Falk L.
        • Fredlund H.
        • Jensen J.S.
        Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection.
        Sex Transm Infect. 2005; 81: 73-78
        • Klebanoff M.A.
        • Schwebke J.R.
        • Zhang J.
        • et al.
        Vulvovaginal symptoms in women with bacterial vaginosis.
        Obstet Gynecol. 2004; 104: 267-272
        • Tibaldi C.
        • Cappello N.
        • Latino M.A.
        • et al.
        Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence.
        Clin Microbiol Infect. 2009; 15: 670-679
        • Lang R.
        • Read R.
        • Krentz H.B.
        • et al.
        A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada.
        BMJ Open. 2018; 8: e021544
        • Koelle D.M.
        • Benedetti J.
        • Langenberg A.
        • et al.
        Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.
        Ann Intern Med. 1992; 116: 433-437